175 related articles for article (PubMed ID: 38928130)
21. Insulinotropic action of 2, 4-dinitroanilino-benzoic acid through the attenuation of pancreatic beta-cell lesions in diabetic rats.
Jahan H; Choudhary MI; Manzoor M; Khan KM; Perveen S; Atta-Ur-Rahman
Chem Biol Interact; 2017 Aug; 273():237-244. PubMed ID: 28625491
[TBL] [Abstract][Full Text] [Related]
22. Enhancing β-cell function and identity in type 2 diabetes: The protective role of Coptis deltoidea C. Y. Cheng et Hsiao via glucose metabolism modulation and AMPK signaling activation.
Zhang S; Zhang Y; Wen Z; Chen Y; Bu T; Yang Y; Ni Q
Phytomedicine; 2024 Jun; 128():155396. PubMed ID: 38547617
[TBL] [Abstract][Full Text] [Related]
23. Role of AMPK in pancreatic beta cell function.
Fu A; Eberhard CE; Screaton RA
Mol Cell Endocrinol; 2013 Feb; 366(2):127-34. PubMed ID: 22766107
[TBL] [Abstract][Full Text] [Related]
24. Identification of 1,2,3-triazole derivatives that protect pancreatic β cells against endoplasmic reticulum stress-mediated dysfunction and death through the inhibition of C/EBP-homologous protein expression.
Duan H; Arora D; Li Y; Setiadi H; Xu D; Lim HY; Wang W
Bioorg Med Chem; 2016 Jun; 24(12):2621-30. PubMed ID: 27157393
[TBL] [Abstract][Full Text] [Related]
25. Insulin Action Research and the Future of Diabetes Treatment: The 2017 Banting Medal for Scientific Achievement Lecture.
Accili D
Diabetes; 2018 Sep; 67(9):1701-1709. PubMed ID: 30135131
[TBL] [Abstract][Full Text] [Related]
26. Rotenone protects against β-cell apoptosis and attenuates type 1 diabetes mellitus.
Wu M; Chen W; Zhang S; Huang S; Zhang A; Zhang Y; Jia Z
Apoptosis; 2019 Dec; 24(11-12):879-891. PubMed ID: 31485878
[TBL] [Abstract][Full Text] [Related]
27. DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes.
Kumar K; Suebsuwong C; Wang P; Garcia-Ocana A; Stewart AF; DeVita RJ
J Med Chem; 2021 Mar; 64(6):2901-2922. PubMed ID: 33682417
[TBL] [Abstract][Full Text] [Related]
28. Introduction to the Kinases in Diabetes Biochemical Society Focused Meeting: are protein kinases good targets for antidiabetic drugs?
Coghlan MP; Smith DM
Biochem Soc Trans; 2005 Apr; 33(Pt 2):339-42. PubMed ID: 15787601
[TBL] [Abstract][Full Text] [Related]
29. Regulating the beta cell mass as a strategy for type-2 diabetes treatment.
Song I; Muller C; Louw J; Bouwens L
Curr Drug Targets; 2015; 16(5):516-24. PubMed ID: 25654737
[TBL] [Abstract][Full Text] [Related]
30. Targeting protein misfolding to protect pancreatic beta-cells in type 2 diabetes.
Costes S
Curr Opin Pharmacol; 2018 Dec; 43():104-110. PubMed ID: 30245473
[TBL] [Abstract][Full Text] [Related]
31. A Review on Molecular Mechanism of Flavonoids as Antidiabetic Agents.
Jasmin ; Jaitak V
Mini Rev Med Chem; 2019; 19(9):762-786. PubMed ID: 30588881
[TBL] [Abstract][Full Text] [Related]
32. NMDAR antagonists for the treatment of diabetes mellitus-Current status and future directions.
Welters A; Klüppel C; Mrugala J; Wörmeyer L; Meissner T; Mayatepek E; Heiss C; Eberhard D; Lammert E
Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():95-106. PubMed ID: 28880473
[TBL] [Abstract][Full Text] [Related]
33. MST1: a promising therapeutic target to restore functional beta cell mass in diabetes.
Ardestani A; Maedler K
Diabetologia; 2016 Sep; 59(9):1843-9. PubMed ID: 27053234
[TBL] [Abstract][Full Text] [Related]
34. Effects of antidiabetic agents on pancreatic beta-cell function in gestational diabetes: is there enough evidence?
Tura A; Göbl C; Pacini G
Expert Opin Drug Metab Toxicol; 2016; 12(2):129-33. PubMed ID: 26609764
[TBL] [Abstract][Full Text] [Related]
35. Antidiabetic effect of polyphenolic extracts from selected edible plants as α-amylase, α -glucosidase and PTP1B inhibitors, and β pancreatic cells cytoprotective agents - a comparative study.
Zakłos-Szyda M; Majewska I; Redzynia M; Koziołkiewicz M
Curr Top Med Chem; 2015; 15(23):2431-44. PubMed ID: 26088348
[TBL] [Abstract][Full Text] [Related]
36. Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatment.
Zhang Z; Jiang J; Yu P; Zeng X; Larrick JW; Wang Y
J Transl Med; 2009 Jul; 7():62. PubMed ID: 19607676
[TBL] [Abstract][Full Text] [Related]
37. Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?
van Raalte DH; Verchere CB
Diabetes Obes Metab; 2017 Sep; 19(9):1205-1213. PubMed ID: 28295962
[TBL] [Abstract][Full Text] [Related]
38. beta-cell failure in diabetes and preservation by clinical treatment.
Wajchenberg BL
Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
[TBL] [Abstract][Full Text] [Related]
39. Potential utility of small tyrosine kinase inhibitors in the treatment of diabetes.
Mokhtari D; Welsh N
Clin Sci (Lond); 2009 Nov; 118(4):241-7. PubMed ID: 19886867
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of p38 mitogen-activated protein kinase exerts a hypoglycemic effect by improving β cell function via inhibition of β cell apoptosis in db/db mice.
Wei X; Gu N; Feng N; Guo X; Ma X
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1494-1500. PubMed ID: 30284474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
